Newsroom

NUMELVI is a once-daily tablet, first-line treatment, and is the only second-generation Janus kinase (JAK) inhibitor indicated for the treatment of pruritus associated with allergic dermatitis including atopic dermatitis and treatment of clinical manifestations of atopic dermatitis in dogs.

Read more